全文获取类型
收费全文 | 20706篇 |
免费 | 2006篇 |
国内免费 | 2271篇 |
专业分类
24983篇 |
出版年
2024年 | 78篇 |
2023年 | 324篇 |
2022年 | 676篇 |
2021年 | 1083篇 |
2020年 | 775篇 |
2019年 | 978篇 |
2018年 | 837篇 |
2017年 | 651篇 |
2016年 | 908篇 |
2015年 | 1336篇 |
2014年 | 1544篇 |
2013年 | 1610篇 |
2012年 | 1915篇 |
2011年 | 1762篇 |
2010年 | 1115篇 |
2009年 | 1014篇 |
2008年 | 1183篇 |
2007年 | 1050篇 |
2006年 | 939篇 |
2005年 | 806篇 |
2004年 | 735篇 |
2003年 | 743篇 |
2002年 | 629篇 |
2001年 | 386篇 |
2000年 | 328篇 |
1999年 | 255篇 |
1998年 | 151篇 |
1997年 | 147篇 |
1996年 | 145篇 |
1995年 | 91篇 |
1994年 | 123篇 |
1993年 | 76篇 |
1992年 | 98篇 |
1991年 | 68篇 |
1990年 | 61篇 |
1989年 | 51篇 |
1988年 | 53篇 |
1987年 | 40篇 |
1986年 | 31篇 |
1985年 | 45篇 |
1984年 | 21篇 |
1983年 | 32篇 |
1982年 | 24篇 |
1981年 | 11篇 |
1980年 | 5篇 |
1979年 | 7篇 |
1978年 | 5篇 |
1977年 | 6篇 |
1975年 | 4篇 |
1973年 | 5篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
991.
Juanjuan Zhang Fuxin Zhao Qun Fu Min Liang Yi Tong Xiaoling Liu Bei Lin Hui Mi Minglian Zhang Qi-Ping Wei Ling Xue Pingping Jiang Xiangtian Zhou Jun Qin Mo Taosheng Huang Jia Qu Min-Xin Guan 《Mitochondrion》2013,13(6):772-781
Mitochondrial m.14484T>C (MT-ND6) mutation has been associated with Leber's hereditary optic neuropathy. Previous investigations revealed that the m.14484T>C mutation is a primary factor underlying the development of optic neuropathy but is not sufficient to produce a clinical phenotype. However, mitochondrial haplogroups have been proposed to modulate the phenotypic manifestation of the m.14484T>C mutation. Here, we performed the clinical, genetic evaluation and complete mitochondrial genome sequence analysis of 41 Han Chinese pedigrees carrying the m.14484T>C mutation. These families exhibited a wide range of penetrances and expressivities of optic neuropathy. The average ratio between affected male/female matrilineal relatives from 41 families was 2:1. The penetrance of optic neuropathy in these Chinese pedigrees ranged from 5.6% to 100%, with the average of 23.8%. Furthermore, the age-of-onset for optic neuropathy varied from 4 to 44 years, with the average of 19.3 years. Sequence analysis of their mitochondrial genomes identified distinct sets of polymorphisms belonging to ten Eastern Asian haplogroups, indicating that the m.14484T>C mutation occurred through recurrent origins and founder events. We showed that mitochondrial haplogroups M9, M10 and N9 increased the penetrance of optic neuropathy in these Chinese families. In particular, these mitochondrial haplogroup specific variants: m.3394T>C (MT-ND1), m.14502T>C (MT-ND4) and m.14693A>G (MT-TE) enhanced the penetrance of visual loss in these Chinese families. These data provided the direct evidence that mitochondrial modifiers modulate the variable penetrance and expressivity of optic neuropathy among Chinese pedigrees carrying the m.14484T>C mutation. 相似文献
992.
993.
Shaoying Lu Yi Wang He Huang Yijia Pan Eric J. Chaney Stephen A. Boppart Howard Ozer Alex Y. Strongin Yingxiao Wang 《PloS one》2013,8(3)
Matrix metalloproteinases (MMPs) remodel tumor microenvironment and promote cancer metastasis. Among the MMP family proteases, the proteolytic activity of the pro-tumorigenic and pro-metastatic membrane-type 1 (MT1)-MMP constitutes a promising and targetable biomarker of aggressive cancer tumors. In this study, we systematically developed and characterized several highly sensitive and specific biosensors based on fluorescence resonant energy transfer (FRET), for visualizing MT1-MMP activity in live cells. The sensitivity of the AHLR-MT1-MMP biosensor was the highest and five times that of a reported version. Hence, the AHLR biosensor was employed to quantitatively profile the MT1-MMP activity in multiple breast cancer cell lines, and to visualize the spatiotemporal MT1-MMP activity simultaneously with the underlying collagen matrix at the single cell level. We detected a significantly higher level of MT1-MMP activity in invasive cancer cells than those in benign or non-invasive cells. Our results further show that the high MT1-MMP activity was stimulated by the adhesion of invasive cancer cells onto the extracellular matrix, which is precisely correlated with the cell’s ability to degrade the collagen matrix. Thus, we systematically optimized a FRET-based biosensor, which provides a powerful tool to detect the pro-invasive MT1-MMP activity at single cell levels. This readout can be applied to profile the invasiveness of single cells from clinical samples, and to serve as an indicator for screening anti-cancer inhibitors. 相似文献
994.
995.
蚯蚓纤溶酶的分离纯化及部分序列的测定 总被引:2,自引:0,他引:2
以新鲜蚯蚓为原料,经过保温抽提、乙醇沉淀、DEAE-SepharoseFastFlow离子交换层析、Lysine-Sepharose4B亲和层析以及SDS-PAGE制备电泳等纯化步聚,得到一种纯度达95%以上的蚯蚓纤溶酶.该酶具有强烈的溶解纤维蛋白的作用及蛋白酶活性,平板法测得其比活性为90OUK单位/毫克蛋白,TAME法测得其比活性为2500O单位/毫克蛋白.酶学性质研究表明其最适反应温度为65℃,最适反应PH值为8.5.该酶的分子量为33kD,等电点为pH3.5.还对该酶进行了氨基酸组成分析,并测定了其N端部分序列. 相似文献
996.
目的:探讨磁共振体素内不相干运动扩散加权成像(intravoxel incoherent motion diffusion weighted MR Imaging,IVIM-DWI)在肺癌所致肺不张的影像诊断中的初步应用。方法:选取独立肺段肺不张病变患者43例,其中肺癌致肺不张31例(肺癌组),局部炎症致肺不张12例(炎症组)。所有患者在药物治疗或手术前均行3.0T磁共振IVIM-DWI检查,b值取0、50、100、200、400、600、800、1000 s/mm~2,分别测量灌注分数(perfusion fraction,f)、真实扩散系数(diffusion coefficient,D)以及关注相关扩散系数(diffusion coefficient from the perfused compartment,D*),对上述参数值进行相关统计学分析,并依据受试者工作特征曲线(Receiver Operating Characteristic,ROC)对各参数的评价效能进行分析。结果:肺癌组的D值、D*值以及f值分别为(0.64±0.16)×10~(-3)mm~2/s、(19.77±6.16)×10~(-3)mm~2/s以及(29.62±9.74)%,而炎症组的D值、D*值以及f值分别为(0.67±0.14)×10~(-3) mm~2/s、(21.14±8.32)×10~(-3)mm~2/s以及(47.62±11.46)%;经比较,肺癌组D值、D*值与炎症组无统计学差异(P0.05),而二者f值差异显著,有统计学意义(P0.01)。f值最佳阈值为38.42%,此时曲线下面积(Area Under Curve,AUC)为0.94,诊断肺癌的特异度为0.89,敏感度为0.93,阳性预测值为0.92,阴性预测值为0.89。结论:磁共振IVIM-DWI技术在肺癌所致肺不张的影像诊断中具有一定的应用价值。 相似文献
997.
This article discusses the historical perspective and the new findings of autophagy and ubiquitin-proteasome system cooperation during the post-fertilization sperm mitophagy, a process that eliminates potentially damaged paternal mitochondrial DNA from an early embryo. New insight into the mechanism that promotes clonal, maternal inheritance of mitochondrial genes may be helpful for managing mitochondrial disease and infertility in humans, as well as reproductive performance and production traits in agriculturally important domestic animals. 相似文献
998.
The prognostic significance of KIT mutations in core-binding factor acute myeloid leukemia (CBF-AML), including inv(16) and t(8;21) AML, is uncertain. We performed a systematic review and meta-analysis of the effect of KIT mutations on the complete remission (CR) and relapse rates and overall survival (OS) of CBF-AML. PubMed, Embase, Web of Science, and the Cochrane Library were searched and relevant studies were included. Negative effect was indicated on relapse risk of CBF-AML (RR [relative risk], 1.43; 95%CI [confidence interval], 1.20–1.70) and t(8;21) AML (RR, 1.70; 95% CI, 1.31–2.21), not on OS of CBF-AML (RR, 1.09; 95% CI, 0.97–1.23), CR (OR [odds ratio], 0.95; 95% CI, 0.52–1.74), relapse risk (RR, 1.12; 95% CI, 0.90–1.41) or OS (RR, 1.03; 95% CI, 0.90–1.18) of inv(16) AML. Subgroup analysis of t(8,21) AML showed negative effect of KIT mutations on CR (OR, 2.03; 95%CI: 1.02–4.05), relapse risk (RR, 1.89; 95%CI: 1.51–2.37) and OS (RR, 2.26; 95%CI: 1.35–3,78) of non-Caucasians, not on CR (OR, 0.61; 95%CI: 0.19–1.95) or OS (RR, 1.12; 95%CI: 0.90–1.40) of Caucasians. This study indicates KIT mutations in CBF-AML to be included in the initial routine diagnostic workup and stratification system of t(8,21) AML. Prospective large-scale clinical trials are warranted to evaluate these findings. 相似文献
999.
Elizabeth D Brooks Haiqing Yi Stephanie L Austin Beth L Thurberg Sarah P Young John C Fyfe Priya S Kishnani Baodong Sun 《Comparative medicine》2016,66(1):41-51
Glycogen storage disease type IIIa (GSD IIIa) is caused by a deficiency of glycogen debranching enzyme activity. Hepatomegaly, muscle degeneration, and hypoglycemia occur in human patients at an early age. Long-term complications include liver cirrhosis, hepatic adenomas, and generalized myopathy. A naturally occurring canine model of GSD IIIa that mimics the human disease has been described, with progressive liver disease and skeletal muscle damage likely due to excess glycogen deposition. In the current study, long-term follow-up of previously described GSD IIIa dogs until 32 mo of age (n = 4) and of family-owned GSD IIIa dogs until 11 to 12 y of age (n = 2) revealed that elevated concentrations of liver and muscle enzyme (AST, ALT, ALP, and creatine phosphokinase) decreased over time, consistent with hepatic cirrhosis and muscle fibrosis. Glycogen deposition in many skeletal muscles; the tongue, diaphragm, and heart; and the phrenic and sciatic nerves occurred also. Furthermore, the urinary biomarker Glc4, which has been described in many types of GSD, was first elevated and then decreased later in life. This urinary biomarker demonstrated a similar trend as AST and ALT in GSD IIIa dogs, indicating that Glc4 might be a less invasive biomarker of hepatocellular disease. Finally, the current study further demonstrates that the canine GSD IIIa model adheres to the clinical course in human patients with this disorder and is an appropriate model for developing novel therapies.Abbreviations: CCR, curly-coated retriever; CPK, creatine phosphokinase; GSD IIIa, glycogen storage disease type IIIa; Glc4, Glcα1-6Glcα1-4Glcα1-4GlcGlycogen storage disease type IIIa (GSD IIIa; OMIM, 232400) is an autosomal recessive disorder caused by mutations in the glycogen debranching enzyme gene (AGL), leading to various clinical signs. The tissues mainly affected are liver, heart, and skeletal muscle. Clinical manifestations include hypoglycemia, elevated serum concentrations of liver and muscle enzymes, hepatomegaly, growth retardation, muscle weakness, cardiac hypertrophy with arrhythmia risk, polycystic ovaries and neuropathy.15,17,29 Current treatments are mainly symptomatic and are not curative. The most frequently used therapies are dietary, such as providing uncooked corn starch to prevent hypoglycemia at young ages and high-protein diets, which have been shown to reverse the extent of cardiomyopathy associated with GSD IIIa.7,8,30,37 In addition, the use of medium-chain triglycerides has shown positive therapeutic effects in patients with GSD Ia and GSD IIIa.11,22 However, dietary therapies do not prevent the long-term complications of GSD IIIa, including hepatic cirrhosis, hepatocellular adenoma, hepatocellular carcinoma, cardiomyopathy, neuropathy, and myopathy.31An appropriate animal model is necessary to test novel therapies and address the long-term effects of GSD IIIa. Recently a mouse model for GSD III has been described that may prove beneficial in testing new therapies.19 However, the limitations of mouse models include a short lifespan that curtails the study of the long-term effects of novel treatments. In addition, a large animal model often mimics human disease more closely than do mouse models, as occurs in GSD type Ia dog models, which exhibit lactic acidosis similar to human patients, a characteristic that mouse models of GSD Ia lack.16 Therefore a naturally occurring large animal model for GSD IIIa may be more effective in terms of the development of new treatments than are available mouse models.GSD IIIa (OMIA, 001577) has been reported to occur in curly-coated retriever dogs (CCR) and is caused by a naturally occurring homozygous frameshift mutation in exon 32 that leads to the deletion of 126 amino acids at the C-terminus of glycogen debranching enzyme.12,40 The dogs in these previous studies proved to have abnormalities similar to those seen in humans affected with the disorder, namely progressive glycogen accumulation in muscle and liver, elevated liver and muscle enzymes (ALP, AST, creatine phosphokinase [CPK], and ALT), and eventual liver fibrosis. However, these animals were not followed beyond 16 mo of age in the earlier studies.12,40 The goal of the current study is to provide biochemical follow-up on these animals and analyze more extensively other tissues and organs involved in GSD IIIa in the dog model. A brief analysis of the naturally high protein diets of GSD IIIa dogs, as well as the effects of an increased protein diet in 2 dogs for the last few months of life, is included.We also include the analysis of a urinary biomarker, Glcα1–6Glcα1– 4Glcα1–4Glc (Glc4), which is a breakdown product of glycogen by α-amylase and neutral α-1,4-glucosidase.32 Elevated levels of Glc4 have been found in urine from patients with GSD types II, III, IV, VI, and IX and may correlate with disease advancement.1,18,24,32 To our knowledge, Glc4 has not been evaluated previously in dogs; we therefore here evaluated the utility of Glc4 as a biomarker of canine GSD IIIa. A correlation of Glc4 levels with liver enzyme concentrations in blood might indicate a role of Glc4 as a less-invasive biomarker for determining the advancement of liver disease in human and canine patients. 相似文献
1000.
降雨和汇流对黑土区坡面土壤侵蚀的影响试验研究 总被引:10,自引:0,他引:10
东北黑土区上坡汇流对坡面土壤侵蚀有重要影响,因此辨析降雨和汇流对黑土区坡面土壤侵蚀的影响对农田土壤侵蚀防治有重要意义。通过设计不同降雨强度和汇流速率以及二者组合的模拟降雨及上方汇流试验,分析了降雨和汇流对黑土坡面侵蚀的影响及其贡献。试验处理包括两个降雨强度(50 mm/h和100 mm/h)、两个汇流速率(50 mm/h和100 mm/h,即:10 L/min和20 L/min)、以及4种不同降雨强度和汇流速率的组合((50+50)mm/h、(50+100)mm/h、(100+50)mm/h和(100+100)mm/h)。结果表明,在50 mm/h和100 mm/h上方汇流引起的坡面侵蚀量仅分别是50 mm/h和100 mm/h降雨引起坡面侵蚀量的1.9%和0.6%;当降雨强度和坡上方汇流速率分别由50 mm/h增加至100 mm/h时,降雨试验处理下的坡面侵蚀量增加6.1倍,汇流试验处理下的坡面侵蚀量增加3.2倍,说明降雨对坡面土壤侵蚀的影响显著大于汇流的作用。在降雨和汇流组合试验中,总供水强度(降雨强度+汇流速率)为150 mm/h时,降雨强度为100 mm/h和汇流速率为50 mm/h组合试验的坡面侵蚀量是降雨强度为50 mm/h和汇流速率为100 mm/h组合试验坡面侵蚀量的7.9倍。在相同汇流条件下,降雨强度由50 mm/h增加到100 mm/h时,降雨强度的增加对坡面侵蚀量的贡献率为89.6%-99.5%;而在相同降雨条件下,坡面汇流速率由50 mm/h增加100 mm/h时,汇流速率的增加对坡面侵蚀量的贡献率为17.2%-78.7%,说明在东北黑土区防治坡面汇流对坡面土壤侵蚀影响也尤为重要。 相似文献